Cancer Moonshot Program Seeks Input Through Online Platform

| April 22, 2016

Vice-President Biden is taking the administration’s last year push to “double the rate of progress towards a cancer cure” to the Vatican and now, the public.  I am beginning to have my doubts as of nearly the month of May…”The community involvement that the initiative garners will allow us to consider novel, creative ideas that might not otherwise have come to NCI’s attention.” 

Community involvement will allow for novel, creative ideas that have may already escaped the NCI over the past 4 decades plus?

Curious to see the quantity and quality of responses.

Here is one idea — Amend HIPAA so we can share information more seamlessly to facilitate some transparencies about patient demographics in information exchange.

Fierce Healthcare (4/20, Budryk) reports that the National Cancer Institute (NCI) “is asking researchers and the public to submit ideas for its National Cancer Moonshot program through an online platform.” The initiative’s Blue Ribbon Panel “will consider submissions in an array of categories, including data sharing, clinical trials, pediatric cancer and tumor evolution.”

The National Institutes of Health’s National Cancer Institute (NCI) is asking researchers and the public to submit ideas for its National Cancer Moonshot program through an online platform. The initiative’s Blue Ribbon Panel will consider submissions in an array of categories, including data sharing, clinical trials, pediatric cancer and tumor evolution. “The goal of the Moonshot Initiative is to accelerate progress in the fight against cancer by swiftly advancing knowledge from … research to new prevention and treatment strategies for patients,” said NCI Acting Director Douglas Lowy, M.D. “The community involvement that the initiative garners will allow us to consider novel, creative ideas that might not otherwise have come to NCI’s attention.”

Announcement

Submit your ideas

Tags: , , , , , ,

Category: Advocacy, Anatomic Pathology, Business, Clinical Laboratories, Clinical Pathology, Current Affairs, Government, Medical Research, Pathology News, Personal, Standards and Guidelines

Comments are closed.